Mode
Text Size
Log in / Sign up

Higher TyG index linked to increased renal function progression risk in patients with CKD stages 3–4High TyG Index Signals Faster Kidney Decline In Advanced Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that higher TyG index associates with increased renal function progression risk in CKD stages 3–4 patients.

This multicenter retrospective cohort study included 53,607 patients with CKD stages 3–4. The primary exposure was the baseline TyG index, compared across quartiles with the second quartile (Q2) as the reference. The median follow-up duration was 31.18 months. The primary outcome was renal function progression, which occurred in 19,619 (36.6%) patients.

Regarding the main results, each 1-unit increase in the continuous TyG index was associated with a 10% higher risk of renal function progression (Hazard Ratio 1.10; 95% CI 1.07–1.12). When analyzed by quartiles, the highest quartile (Q4) demonstrated a significantly increased risk compared to Q2 (Hazard Ratio 1.17; 95% CI 1.12–1.22). Additionally, the association between the TyG index and renal function progression was non-linear and U-shaped, with the lowest risk (nadir) observed at a TyG index of approximately 8.6–8.8.

Safety and tolerability data were not reported, as were specific adverse events or discontinuations. The study noted that results were robust in sensitivity analyses, including a competing-risk model. However, because this was a retrospective cohort study, the TyG index is described as an independent predictor rather than a causal agent. No funding conflicts were reported.

The TyG index may serve as a valuable tool for early risk stratification in patients with CKD stages 3–4. Clinicians should interpret these associations cautiously, recognizing the limitations inherent to observational research.

Imagine checking your blood sugar to see how your body handles energy. Now imagine doing something similar to check your kidneys before they fail. That is exactly what new research suggests is possible. Doctors have found a simple number in a standard blood test that warns of trouble ahead.

Kidney disease is a silent problem that affects millions. Many people do not know they have it until their organs stop working well. Once the disease reaches stages 3 or 4, the damage is significant. Current tools to predict how fast the disease will get worse are often complicated or not available everywhere.

But here is the twist. A new study looks at a number called the TyG index. This number comes from two things you already measure: your triglycerides and your blood sugar. Together, they tell a story about insulin resistance. Insulin resistance happens when your cells ignore insulin, the hormone that helps move sugar into your cells.

A Simple Number With Big Clues

Think of your body like a factory. Insulin is the manager telling workers to move sugar into storage. When the manager is ignored, sugar builds up in the blood. This is bad for the kidneys. The TyG index acts like a smoke alarm for this problem. It does not measure kidney damage directly. Instead, it measures the fuel problem that causes the damage.

The researchers looked at over 53,000 patients. These patients had already been diagnosed with kidney disease stages 3 or 4. They tracked these people for about two and a half years. The goal was to see if the TyG index could predict who would need dialysis or a transplant sooner.

The results were clear and consistent. Patients with the highest TyG index numbers faced a higher risk of their kidney function dropping. Specifically, for every one-unit increase in the index, the risk of progression went up by 10%. This is a significant jump in risk.

The relationship was not a straight line. It formed a U-shape. This means the risk was lowest at a specific middle range of the index. The risk rose again if the number got too high or too low. This finding surprised some experts who expected a simple straight-line relationship.

Why The Shape Matters

Why does the shape matter? It tells doctors that both very high and very low levels of this marker can be risky. However, the highest risk group had the most dangerous numbers. This group included people with severe insulin resistance. Their bodies were struggling hard to manage sugar and fat. This struggle puts extra stress on the kidneys.

The study also checked for other factors. Doctors looked at age, blood pressure, and other common issues. Even after accounting for these, the TyG index still predicted outcomes. This makes it an independent predictor. It adds new information that other tests do not provide.

This doesn't mean this treatment is available yet.

The TyG index is cheap and easy to calculate. Most labs already run the tests needed to find it. You do not need a special machine or a rare drug. This makes it very attractive for doctors in busy clinics. It could help them spot patients who need closer watching sooner.

There are limits to what this study shows. The data came from one large system in China. Other countries may have different diets and lifestyles. These differences could change how the index works elsewhere. Also, the study looked at people who already had kidney disease. We do not know if it works for people with early-stage issues.

Doctors will need to test this in different places. They must see if the U-shape holds true everywhere. Until then, this tool remains a promising idea. It is not a replacement for current care. It is a potential helper for better planning.

What Happens Next

This research opens a door for better patient care. If more studies confirm these results, the TyG index could become a standard part of kidney checks. It would help doctors decide who needs aggressive treatment sooner. Patients could avoid sudden drops in kidney function.

For now, talk to your doctor about your risk factors. High blood sugar and high triglycerides are things you can manage. Diet and exercise help improve insulin sensitivity. These steps lower your TyG index naturally. Managing these numbers is a powerful way to protect your kidneys.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe progression of chronic kidney disease (CKD) is a major public health issue. Insulin resistance (IR) is a key mechanism, but simple biomarkers to predict progression in patients with established CKD stages 3–4 are needed. The Triglyceride-glucose (TyG) index is a reliable surrogate for IR. We aimed to investigate the longitudinal association between the baseline TyG index and the risk of renal function progression in patients with CKD stages 3–4.MethodsThis multicenter retrospective cohort study included 53,607 patients with CKD stages 3–4 from the China Renal Data System (CRDS) between 2005 and 2022. The baseline TyG index was calculated, and participants were divided into quartiles. The primary outcome was renal function progression. We used multivariate Cox proportional hazards models, restricted cubic splines (RCS), subgroup analyses, and competing-risk models to assess the association.ResultsDuring a median follow-up of 31.18 months, 19,619 (36.6%) patients experienced renal function progression. After full multivariate adjustment, each 1-unit increase in the continuous TyG index was associated with a 10% higher risk of renal function progression (Hazard Ratio [HR] 1.10, 95% CI 1.07–1.12). Compared to the second quartile (Q2, reference), the highest quartile (Q4) had a significantly increased risk (HR 1.17, 95% CI 1.12–1.22). The RCS analysis revealed a non-linear, U-shaped association between the TyG index and renal function progression, with the lowest risk (nadir) at a TyG index of approximately 8.6–8.8. This U-shaped association was consistent across subgroup analyses and robust in sensitivity analyses, including a competing-risk model treating all-cause death as the competing event.ConclusionThe TyG index is an independent predictor of renal function progression in patients with CKD stages 3–4, demonstrating a U-shaped relationship. As an inexpensive and readily available marker, the TyG index may serve as a valuable tool for early risk stratification in this high-risk population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.